These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8331656)
21. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains. Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4. Kasai N; Tsumoto K; Niwa S; Misawa S; Ueno T; Hayashi H; Kumagai I Biochem Biophys Res Commun; 2001 Feb; 281(2):416-24. PubMed ID: 11181064 [TBL] [Abstract][Full Text] [Related]
23. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen. Jäger M; Plückthun A J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781 [TBL] [Abstract][Full Text] [Related]
24. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency. Tan PH; Sandmaier BM; Stayton PS Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949 [TBL] [Abstract][Full Text] [Related]
25. Backbone assignment, secondary structure and protein A binding of an isolated, human antibody VH domain. Riechmann L; Davies J J Biomol NMR; 1995 Sep; 6(2):141-52. PubMed ID: 8589603 [TBL] [Abstract][Full Text] [Related]
26. Nuclear magnetic resonance structural and ligand binding studies of BLBC, a two-domain fragment of barley lectin. Weaver JL; Prestegard JH Biochemistry; 1998 Jan; 37(1):116-28. PubMed ID: 9425031 [TBL] [Abstract][Full Text] [Related]
27. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg. Yang X; Hu W; Li F; Xia H; Zhang Z Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720 [TBL] [Abstract][Full Text] [Related]
28. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer]. Wang Y; Li X; Chen W Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168 [TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond. Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187 [TBL] [Abstract][Full Text] [Related]
30. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris. Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401 [TBL] [Abstract][Full Text] [Related]
31. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies. Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806 [TBL] [Abstract][Full Text] [Related]
32. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains. van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026 [TBL] [Abstract][Full Text] [Related]
33. Role of mouse VH10 and VL gene segments in the specific binding of antibody to Z-DNA, analyzed with recombinant single chain Fv molecules. Brigido MM; Polymenis M; Stollar BD J Immunol; 1993 Jan; 150(2):469-79. PubMed ID: 8419479 [TBL] [Abstract][Full Text] [Related]
34. Anti-V region framework antibodies affect the ligand binding of VL dimer. Ben-Neriah Y; Givol D; Gavish M Eur J Immunol; 1979 Jan; 9(1):91-3. PubMed ID: 108113 [TBL] [Abstract][Full Text] [Related]
35. Solution NMR structure and backbone dynamics of the major cold-shock protein (CspA) from Escherichia coli: evidence for conformational dynamics in the single-stranded RNA-binding site. Feng W; Tejero R; Zimmerman DE; Inouye M; Montelione GT Biochemistry; 1998 Aug; 37(31):10881-96. PubMed ID: 9692981 [TBL] [Abstract][Full Text] [Related]
36. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain. Arndt KM; Müller KM; Plückthun A J Mol Biol; 2001 Sep; 312(1):221-8. PubMed ID: 11545598 [TBL] [Abstract][Full Text] [Related]
37. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments. Reiter Y; Brinkmann U; Lee B; Pastan I Nat Biotechnol; 1996 Oct; 14(10):1239-45. PubMed ID: 9631086 [TBL] [Abstract][Full Text] [Related]
38. A peptide mimic of an antigenic loop of alpha-human chorionic gonadotropin hormone: solution structure and interaction with a llama V(HH) domain. Ferrat G; Renisio JG; Morelli X; Slootstra J; Meloen R; Cambillau C; Darbon H Biochem J; 2002 Sep; 366(Pt 2):415-22. PubMed ID: 11996668 [TBL] [Abstract][Full Text] [Related]
39. Solid-state NMR yields structural constraints on the V3 loop from HIV-1 Gp120 bound to the 447-52D antibody Fv fragment. Sharpe S; Kessler N; Anglister JA; Yau WM; Tycko R J Am Chem Soc; 2004 Apr; 126(15):4979-90. PubMed ID: 15080704 [TBL] [Abstract][Full Text] [Related]